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Abstract
Background: Many patients with a congenital extrahepatic portosystemic shunt (PSS) do not tolerate an immediate
shunt closure. Therefore, slow progressive techniques were developed. To evaluate the success of shunt closure
diagnostic imaging is essential to identify possible residual blood flow through the shunt vessel. There is a lack of
information about the reliability of computed tomography angiography (CTA) for evaluating residual flow through a
PSS after treatment. The purpose of this prospective study was to compare the results of CTA with splenoportography.
Three months after cellophane banding CTA and splenoportography were performed in 20 dogs and reviewed by
three independent examiners, respectively. In both imaging modalities the presences of a residual shunt was judged as
present or absent and the extent of visibility of portal vasculature was recorded.
Results: Based on the evaluation of the splenoportography residual flow through shunt was present in 6 dogs. The
classification of residual shunt present or absent showed a substantial to perfect agreement (κ = 0.65–1.00) between
the observers in splenoportography and a slight to moderate agreement (κ = 0.11–0.51) for CTA. Sensitivity and
specificity varied between 0.50 and 1.00 and 0.57–0.85, respectively. Significant correlation between CTA and
splenoportography for the classification of residual shunt was present only in one observer but not in the other two.
Conclusion: More studies were classified as residual shunt positive with CTA compared to splenoportography. It
remains unclear which methods do reflect reality better and thus which method is superior. The greater inter-rater
agreement for splenoportography suggests a greater reliability of this technique.
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Background
Portosystemic shunts describe anomalous vessels connect-
ing the portal venous system to the systemic venous system
and subsequently allow blood to bypass the liver. They can
be classified as intrahepatic or extrahepatic [1, 2]. As a
consequence of blood bypassing the liver there is a lack in
hepatotrophic substances, especially insulin, and subsequent
hepatic atrophy [3, 4]. Toxins from the intestines, such as
ammonia or aromatic amino acids, in the systemic cir-
culation are accounted for the clinical signs [2]. Blood
work only allows for the suspicion of the presence of a
portosystemic shunt (PSS). Diagnostic imaging modalities
are used to prove vascular anomalies of the portal system.
Portography is the gold-standard for the visualization of
the portal system and diagnosis of PSS in veterinary medi-
cine [1, 5–8]. However, portography is replaced by other,
less invasive imaging modalities like ultrasonography,
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computed tomography angiography (CTA) and magnetic
resonance imaging [5, 9–12].
Long-term prognosis is better in animals undergoing
complete shunt occlusion compared to animals showing
a residual flow through the shunt vessel [13]. Therefore,
the main objective of surgical or interventional therapy
is a complete occlusion of the PSS to establish normal
liver function. An immediate complete occlusion is not
possible in most animals due to the risk of fatal portal
hypertension [13, 14]. Extravascular surgical techniques
leading to slow occlusion include the use of an ameroid
constrictor or cellophane bands [15–18]. Gradual occlusion
of the PSS by cellophane banding occurs as a result of
inflammation and thrombosis [18]. After cellophane
banding, continued shunting can occur, either due to
incomplete occlusion or due to the development of
multiple acquired shunts [19].
One case report demonstrates the use of CTA in the
evaluation of shunt closure after cellophane banding [20].
However, there is a lack of information in the literature
concerning the reliability of CTA to assess the shunt
closure after surgical treatment of PSS by cellophane
banding. The objective of this prospective study was to
compare CTA with splenoportography in the assessment
of residual blood flow through the shunt vessel 3 months
after cellophane banding.
Methods
Animals
All investigations were conducted in strict compliance
with the restrictions of the German Animal Protection
Law. The study was conducted prospectively and was
approved by the Committee on the Ethics of Animal
Experiments of the Justus Liebig University and local
Hessian government (reference number GI 18/17 Nr. A
43/2012).
Twenty client owned dogs with a single congenital
extrahepatic portosystemic shunt were included in this
study. The owners of the dogs gave permission for
their animals to be used in this study. The dogs were
treated 3 months previously by cellophane banding
without intraoperative attenuation as described previously
[21]. A ventral midline laparotomy was performed and the
shunt vessel was visualized. The cellophane band was
placed around the shunt vessel and for fixation of the
cellophane band a non-metal hemoclip (Hem-o-lok®,
Teleflex Medical, Kernen, Germany) was used. No other in-
clusion criteria were applied. The dogs underwent a phys-
ical examination as well as a complete hematology and
serum chemistry prior to anesthesia. An intravenous (IV)
catheter was placed in a cephalic vein. Anaesthesia was
induced with acepromazin (Vetranquil®, CEVA GmbH,
Düsseldorf, Germany) and l-polamidon (L-Polamivet®,
Intervet, Unterschleissheim, Germany) and maintained
using isoflurane (IsoFlo®, Ecuphar GmbH, Greifswald,
Germany). Each patient was placed in sternal recumbency.
Ventilator aided hyperventilation and breath-hold tech-
niques were used to eliminate motion during scanning.
Computed tomography
All images were obtained using a 16-slice CT scanner
(Brilliance 16, Philips Healthcare, Best, Netherlands).
Patients were positioned in sternal recumbency on the
patient table of the CT scanner. Plain transverse images
of the abdomen were acquired in helical mode using
the following scanning parameters: 2 mm slice thickness,
pitch of 1, tube current of 313 mA, tube voltage of 120 kVp
and 0.75 s rotation time. Transverse images were recon-
structed using a medium-frequency, non-enhancing filter
with a 512x512 matrix. Scan direction was from caudal to
cranial. To determine the scan delay for optimal contrast
enhancement of the portal vein a dynamic CT scan was
performed caudal to the porta hepatis.
For the dynamic CT scan a single slice was imaged
sequentially to evaluate contrast enhancement of the
portal vein over time. A low dose (150 mg Iodine/kg
body weight) of contrast medium (Xenetix® 300, Guerbet,
Sulzbach, Germany) was administered IV using a power
injector (Injektron CT2, MEDTRON, Saarbruecken,
Germany). The injection rate was 3 ml/s. Every 2 s one
transverse image was acquired until twenty images were re-
corded. Scanning parameters for the dynamic scan were,
6 mm slice thickness, tube current of 40 mA, tube voltage
of 120 kVp and 0.75 s rotation time. In the resulting image
series a region of interest was positioned over the portal
vein. A time attenuation curve was generated from which
the time to peak enhancement was determined. The opti-
mal time to start the CTA was calculated by subtracting
the time the scanner needed to reach the position of
the dynamic CT scan from the time to peak enhancement.
For the CTA contrast medium was administered at a dose
of 600 mg Iodine/kg body weight and an injection rate of
3 ml/s. The scan was started after the determined delay.
Scan parameters were identical to the precontrast scan. A
second scan was performed subsequently to the portal
phase in cranial to caudal direction.
Splenoportography
For splenoportography the patient was placed in dorsal
recumbency on the table of a biplane fluoroscopy system
(Bicor HS, Siemens Healthcare, Erlangen, Germany).
Under ultrasonographic guidance a 20 gauge venous cath-
eter was inserted percutaneously into the splenic paren-
chyma. Contrast medium (Xenetix® 300, Guerbet, Sulzbach,
Germany) was administered manually into the spleen
(300 mg Iodine/kg body weight), at a flow rate of approxi-
mately 2 ml/s. During breath-hold lateral and dorsoventral
angiographic cineloops were acquired simultaneously at a
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frame rate of 12.5 images/s. Fluoroscopic acquisition started
immediately before contrast injection and lasted for 10 s.
One cineloop was recorded, no follow up sequences were
acquired.
Image analysis
Images were anonymized, patient information was
removed from the image by deleting it from the DICOM
information and an arbitrary number was assigned for the
CT images and the digital cineloops of the splenoporto-
graphy. Hence, reviewers assessing CTA images and
splenoportography cineloops were blinded to which studies
belonged to the same patient. To minimize image recogni-
tion review of splenoportography and CTA images was per-
formed 6 months after the last set of images was acquired.
CTA images were reviewed in a soft tissue window
by two board certified radiologists (AH and TS) and a
radiology resident (SS). Original pre- and post-contrast
transverse as well as multiplanar reformatted images were
available for review. Reviewers could modify image orienta-
tion and windowing individually to optimize the images
according to personal preference. Residual flow was judged
as “absent” if there was no connection visible between the
shunt vessel and the systemic vein (Fig. 1). Residual flow
was classified as “present” if contrast was visible in the
shunt vessel entering the systemic vein (Fig. 2). In addition,
the branching pattern of the portal vein within the liver was
graded using a simplification of a previously published
angiographic grading system [22]: grade 1 (no intrahepatic
portal vasculature visible), grade 2 (portal vessel stump
visible within the liver parenchyma) or grade 3 (good
portal vessel branching within the liver parenchyma).
Digital cineloops of the splenoportography were assessed
by one board certified cardiologist (MS), one board certified
radiologist (AH) and one radiology resident (SS). Also in
splenoportography presence of a residual shunt was graded
based on the visibility of flow of contrast medium to the
systemic vein. The branching pattern of the portal vein in
the liver was graded using the same modified grading
system as for the CTA.
Statistical analysis
Statistical analysis was performed using commercially
available statistics software (SPSS® Statistics 22, IBM
Corporation, Armonk NY, USA). Inter-rater agree-
ment for residual shunt judgement was measured by
Cohen’s kappa coefficient in splenoportography and
CTA, separately.
The splenoportography evaluation of the examiner (MS)
with the greatest experience in angiography of portosystemic
shunts, based on long standing clinical practice in this
technique, was used as reference for further analysis to
which the results of splenoportography and CTA of the
other reviewers were compared to.
Fisher’s exact was used for comparison of residual shunt
classification between the results of our reference (most
experienced observer, MS) for splenoportography and the
three different CTA analyses. Sensitivity and specificity
were calculated for each observer of the CTA separately.
Cramer’s V correlation analysis was used for comparison
of portal vein branching between CTA, assessed by the
three different observers, and the results of splenoporto-
graphy of our set reference (MS). Significance level was
set at p ≤ 0.05.
Results
Dogs included in this study were five mix-breed dogs,
four Pug dogs, two Yorkshire terriers, two Miniature
Pinschers and one Chihuahua, Bolognese, Maltese, Parson
Russell terrier, Shi Tzu and Shetland sheepdog, respectively.
There were ten female and ten male dogs. The median age
of the patients was 15.5 months (range 6–68 month). The
median body weight was 4.63 kg (range 2.0–9.7 kg). Based
on intraoperative angiography ten dogs had a portocaval
Fig. 1 Maximum intensity projection in transverse view (a) and the corresponding splenoportographic image in dorsoventral view (b) demonstrating
a shunt vessel of a gastroduodenal-caval shunt which was graded as “closed” in splenoportography and CTA. Note the portal vein (PV), splenic vein
(SpV) and the former shunt vessel (PSS)
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shunt arising from the gastroduodenal vein, ten dogs had
shunt arising from the gastrosplenic vein entering the
caudal vena cava (n = 6), the azygos vein (n = 2) or the
phrenic vein (n = 2) (Table 1).
Residual shunting was found in splenoportography in
6/20 (30%) dogs by the most experienced observer.
Eight to eleven dogs (40–55%) showed a residual shunt
in CTA for the three examiners of the CTA.
The results of splenoportography and CTA including
the respective shunt type are summarized in Table 1.
All CTA studies showed a subjective good contrast
enhancement of the portal vasculature. Inter-rater agree-
ment for splenoportography was perfect for one observer
(κ = 1.0) (comparison of MS with SS) and for two ob-
servers substantial (κ = 0.66) (comparison of AH with MS
and AH with SS). Inter-rater agreement for CTA was
slight to moderate for all observers (κ = 0.12; 0.38; 0.52)
(comparison of AH with TS; AH with SS; TS with SS).
Between splenoportography and CTA significant associ-
ation was found for one observer (p = 0.001), first author
of this paper (SS), but not for the other two observers
(p = 0.16 (TS); 0.64 (AH)). Compared to the results of
the splenoportography the sensitivity of CTA for residual
shunt detection was 50% (AH); 83% (TS); 100% (SS),
respectively. The specificity of CTA was 57% (TS); 64%
(AH); 86% (SS), respectively.
In splenoportography the most experienced observer
(MS) classified the portal vein branching as grade 1 in
three dogs and grade 3 in 17 dogs. Three observers clas-
sified the portal vein branching in CTA as grade 2 in
none (AH), two (TS) and three dogs (SS); all remaining
dogs were classified with grade 3. The results for each
observer in relation to the type of shunt are summarized
in Table 1.
Compared to splenoportography the CTA results had
a fair correlation (Cramers-V = 0.21 (SS); 0.33 (TS)) in
two observers for the assessment of the branching of the
Fig. 2 Maximum intensity projection in transverse view (a) and the corresponding splenoportographic image in dorsoventral view (b)
demonstrating a gastrospleno-caval shunt which was graded as “open” in splenoportography and CTA. Note the portal vein (PV), splenic vein
(SpV) and the shunt vessel. There is still a fine hyperattenuating band (arrow) visible between the splenic vein and the caudal vena cava (CVC)
Table 1 Shunt type, residual shunting and intrahepatic portal
vein branching classified in splenoportography and computed
tomography angiography by different observers (MS, TS, AH, SS)
Patient Type of shunt Residual shunting Portal vein branching
Origin – End SP
(MS)
CTA
(TS)
CTA
(AH)
CTA
(SS)
SP
(MS)
CTA
(TS)
CTA
(AH)
CTA
(SS)
1 GdV – CVC - + + + 3 3 3 3
2 GsV – CVC - - - - 3 3 3 3
3 GdV – CVC - + + + 3 3 3 2
4 GsV – CVC - - - - 3 3 3 3
5 GdV – CVC + + - + 1 2 3 2
6 GsV – PhV + + - + 3 3 3 3
7 GsV – CVC + + + + 1 3 3 3
8 GdV – CVC - - + - 3 3 3 3
9 GsV – AzV - - - - 3 3 3 3
10 GdV – CVC - + - - 3 3 3 3
11 GdV – CVC - - - - 3 3 3 3
12 GsV – CVC + - + + 3 3 3 3
13 GdV – CVC - + + - 3 2 3 3
14 GdV – CVC - - + - 3 3 3 3
15 GdV – CVC - + - - 3 3 3 3
16 GsV – PhV - - - - 3 3 3 3
17 GsV – CVC + + + + 1 3 3 3
18 GsV– CVC - - - - 3 3 3 3
19 GdV– CVC - + - - 3 3 3 3
20 GsV – AzV + + - + 3 3 3 2
SP splenoportography, CTA computed tomography angiography, GdV
gastroduodenal vein, GsV gastrosplenic vein, CVC caudal vena cava, PhV
phrenico vein, AzV azygos vein
- residual shunt present
+ no residual shunt visible
1 no intrahepatic portal vasculature visible
2 portal vessel stump visible
3 good portal vessel branching
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portal vein. In the third observer (AH) no correlation
could be calculated because all dogs classified as grade 3
in CTA.
Discussion
Currently portography is considered the gold-standard
for the assessment of a portosystemic shunt [1, 5, 6, 8].
However, sensitivity or specificity values are not reported
for splenoportography [23]. CTA has proven to be a reli-
able imaging modality for diagnosing an extrahepatic
PSS in dogs [5, 12, 24–26]. Sensitivity and specificity for
detection of an extrahepatic PSS using CTA are reported
to be 96 and 89%, respectively [27]. However, studies
assessing the value of imaging techniques in the detec-
tion of residual flow through a PSS after treatment are
lacking.
The study was performed 3-month post-surgery. This
is the standard interim for the re-check after cellophane
banding in our clinic. An earlier re-check would have
most likely lead to an increased number of patients
showing a residual flow, which would have been beneficial
for the statistical evaluation in our study. It is reported
that 2–6 month post-surgery 85% of dogs show a normal
liver function, however no imaging was performed for
shunt evaluation [15]. Others report that it takes more
than 6 months for shunt occlusion to occur depending on
the size of the shunting vessel [21]. Therefore, we did not
expect that most patients show complete shunt attenu-
ation after 3-month.
Inter-rater agreement was only slight to moderate
(κ = 0.12 to 0.52) for CTA, whereas for splenoporto-
graphy it was substantial to perfect (κ = 0.66 to 1.0).
We found a varying sensitivity (50 to 100%) and speci-
ficity (57 to 85%) for the assessment of residual blood
flow through the shunt vessel three months after cel-
lophane banding using CTA.
During a consensus review of the CTA images, which
was performed during preparation of the paper after
statistical analysis, in order to identify possible causes
for the wide variation in sensitivity and specificity and
the poor inter-rater agreement between the different ob-
servers a fine hyperattenuating band between the portal
vein and the systemic vein visible on some CTA images,
showing no detectable flow during splenoportography
(Fig. 3) was identified. This band has been assessed as a
sign of residual flow through the shunt by some observers
(residual flow present), whereas others interpreted it as
contrast enhancing inflammatory reaction without residual
blood flow encapsulating the previous shunting vessel.
It remains unclear if this band represents a residual
flow through the shunt vessel or not. Further assess-
ment of this finding would have required surgical ex-
ploration and for example dye injection (e.g., methylene
blue) in the previous shunt vessel (stump) or removal
with histopathological examination of the tissue. All dogs
were clinically unremarkable, therefore another surgery was
not an option. Another possibility for the future might be
the comparison between functional shunt closure accessed
by laboratory tests and both imaging techniques.
CT has a possible submillimeter spatial resolution,
modern fluoroscopy systems can only discriminate 2.5
to 3 line pairs per millimeter [28–30]. In addition, CT
offers superior contrast resolution, allowing for a better
distinction of structures with only minor differences in
x-ray attenuation [31]. Therefore, splenoportography may
under diagnose residual flow. Minimal flow through a
small residual lumen of a shunt might not be visible on
the fluoroscopy screen due to a lower spatial and contrast
resolution compared to CT.
The small number of patients further enhances the
wide variation in sensitivity and specificity between the
different observers. It would be interesting if a dynamic
scan over the shunt vessel can help to discriminate
between inflammatory reaction and residual flow. For
example, by assessing the time of arrival of the contrast
medium in the area of shunt attenuation.
Contrast medium injection in splenoportography was
done via injection into the splenic parenchyma under
ultrasound guidance. Laceration of the spleen is a possible
complication using this technique. However, ultrasono-
graphic identification and puncturing of the spleen does
help to minimize the risk of laceration of the spleen.
Nevertheless, it requires the radiologist to be present in
the examination room during image acquisition. Scatter
radiation during splenoportography and subsequent
exposure to radiation is a major downside of this pro-
cedure [1, 32].
Application of contrast media for a CTA is done by
intravenous injection. Thus, allowing for the usage of a
high power injector with a defined injection rate. Using
a power injector allow for the personal to stay outside
the scanner room during injection and image acquisition,
avoiding radiation exposure to personal. Application of
contrast medium for CTA of the portal system was done
using a cephalic vein. Contrast medium applied by a saphe-
nous vein can lead to beam hardening artifacts and a retro-
grade filling of the hepatic veins with contrast medium
[26]. Injection into the splenic parenchyma as in splenopor-
tography is also described [33]. This would require the
presence of a person in the scanner room if images should
be acquired during the portal phase. For radiation safety
reasons this is not allowed in our country and a possible
benefit of this technique should be critically questioned in
countries where the presence of person in the room during
radiation is legally allowed.
CTA was planned on the basis of a dynamic CT scan
as it has been recommended in a previous study [12].
Other options would have been the use of bolus tracking
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or a body weight dependent delay [5, 33, 34]. Using the
bolus tracking technique, a region of interest is placed
over the vessel which is going to be evaluated and the
scan starts automatically when a given threshold value is
reached. Respiration can cause artifacts leading to an in-
advertent too early or late start of the CTA by moving
the tracked vessel out of the region of interest [33, 34].
Using a published body weight dependent delay for the
starting of the CT angiography proofed not practical in
our clinic. The published values differ between 1.41 to
4.12 s per kg body weight, leading to wide range of pos-
sible starting points varying more than 100% for a given
weight category [5].
For injection we used a constant injection rate of 3 ml/s.
We performed a test injection to calculate the optimal tim-
ing for scanning. Therefore, we encountered no problems
in acquiring images during peak enhancement. In patients
with an insufficient attenuation of the shunt vessel no
contrast enhancement of the entire intrahepatic portal
vasculature could be visualized in the splenoportography.
However, in CTA it was always possible, in this study, to
visualize the complete intrahepatic portal vasculature even
if the shunt vessel was still partially open. In splenoporto-
graphy only minimal hemodilution of the contrast medium
from the splenic blood pool occurs, therefore one would
expect a distinct contrast enhancement of the portal vascu-
lature also within the liver parenchyma [35].
In CTA hemodilution of contrast medium is much
greater as in splenoportography owing to the peripheral
injection technique. Nevertheless, we encountered a greater
contrast enhancement and visibility of portal vasculature in
CTA. One reason most likely contributing to the lack of
visibility of the intrahepatic portal vessels in splenopor-
tography is the location of contrast injection in relation
to the shunt location. All three patients in which no
contrast enhancement of the entire intrahepatic portal
vasculature could be observed using splenoportography
had a shunt type which involves mainly (spleno to caval
shunt; n = 2) or partially (right gastric with left gastric
to caval, n = 1) the splenic vein leading to a large proportion
of the injected contrast medium flowing through the in-
completely occluded shunt and not into intrahepatic portal
vein branching. For these shunt forms it may have been
better to inject the contrast medium directly into the portal
vein. However, this problem has not been described previ-
ously and was only encountered during consensus review
of all splenoportographies after statistical analysis, during
manuscript preparation. Future studies may profit from this
finding and use a different approach for contrast injection
in PSS involving the splenic vein.
Another explanation contributing to the lack of visibility
of the intrahepatic portal vessels in splenoportography is
that the contrast resolution of the fluoroscopic images from
splenoportography is too low to show blood that contains
only a small amount of contrast medium entering the
intrahepatic portal vasculature. Computed tomography
is known to have a better contrast resolution compared
to fluoroscopy [31]. With CT, minimal differences in
attenuation can be detected, which go undetected with
fluoroscopy. So, a faint contrast filling of the intrapar-
enchymal liver vasculature can be depicted with CT
but not with fluoroscopy. Based on the findings of CTA
we consider this explanation the most likely cause for
the inability to see the intrahepatic portal vasculature
using splenoportography in patients with incomplete
shunt occlusion. It seems unlikely that an insufficient con-
trast medium dose is the cause for the lack of visualization
of the intrahepatic portal vasculature. Even considering
that some contrast medium remained within the splenic
parenchyma and therefore did not contribute to the blood
pool good enhancement of the splenic vein draining the
contrast medium from the spleen was present in all cases.
Fig. 3 Maximum intensity projection in transverse plane (a) and dorsoventral view projection in splenoportography (b) of a dog with gastroduodenal-caval
shunt, which was graded as “open” in CTA and “closed” in splenoportography. In CTA there is a fine hyperattenuating connection (arrow) visible between the
former shunt vessel (PSS) and the caudal vena cava (CVC). Note the portal vein (PV) ventral to the caudal vena cava and medial to the dilated epigastric vein
(Ep) in CTA images. In splenoportography there was no flow of contrast medium into the caudal vena cava visible. All intrahepatic portal
branches (PV) can be clearly seen in splenoportography with a fine arborization within the liver parenchyma
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Thus the amount of contrast medium injected was con-
sidered sufficient and good opacification of the intrahe-
patic portal vasculature would have been expected. In
addition pooling of contrast medium within the splenic
parenchyma occurred in all patients, also in patients in
which the intrahepatic vasculature was visible in sple-
noportography. Although quantification of how much
contrast medium remained in the splenic parenchyma
was not possible, we assume the percentage was similar
in all patients thus the effect on the visibility of the
intrahepatic portal vasculature was assumed to be simi-
lar between patients with visible and invisible intrahe-
patic portal vasculature.
A limitation of this study is the small number of
observers for both modalities; in addition not every ob-
server assessed each imaging modality further decreas-
ing the number of observers per imaging modality. We
decided for this experimental set up for multiple rea-
sons. First, the observers which did only review images
of one image modality had no experience in the other
imaging technique, thus we expected a poor perform-
ance which would have led to skewing of our results.
The second reason was to avoid subconscious influ-
ence by the knowledge of the result of the other im-
aging modality in at least some of our observers. To
assess the unbiased potential of CT we therefore de-
cided that the most experienced observers should only
read the CT images. The observers reading images of
both modalities had a low to medium experience in
reading splenoportographic and CTA images, thus un-
wanted bias of the results based on a lack of experi-
ence with one imaging technique was not expected.
This study was meant as a pilot study evaluating CTA
for assessing residual shunting after partial shunt clos-
ure, we therefore considered a total of four observers
sufficient. However, overall a larger number of ob-
servers would have been ideal.
Another limitation might be some degree of image
recognition for the first author as all CTA studies were
performed by him. We tried to minimize this risk by
anonymizing the images and having a time gap of at
least 6 months between image acquisition and analysis.
The overall better performance of the first author of this
paper might be the result of SS being trained by MS for
splenoportography analysis, leading to a stronger correl-
ation between the two.
Another limitation of our study is the relatively low
number of dogs included (twenty animals).
Further studies evaluating the value of CT to assess
the presence of residual shunting are necessary.
Conclusion
In summary, the results for CTA are heterogeneous
compared to splenoportography for the evaluation of a
possible residual flow through the shunt vessel. More
studies were classified as residual shunt positive with the
CTA compared to the splenoportography. However, it
remains unclear which methods do reflect reality better.
The better spatial and contrast resolution of CT might
be superior to splenoportography in detecting residual
blood flow through a shunt vessel, which remains invisible
on splenoportography. Further studies are necessary to
judge which imaging modality is correct. However, the
substantial to perfect inter-rater agreement for splenoporto-
graphy and only slight to moderate inter-rater agreement
for CTA suggests a greater reliability of splenoportography
due to less observer related effects on the results.
In any case, CTA is advantageous for the anatomic
assessment of the portal vasculature.
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